Olszynski Wojciech P, Davison K Shawn, Adachi Jonathan D, Brown Jacques P, Hanley David A
Saskatoon Osteoporosis Centre and Camos Centre (Saskatchewan), Saskatoon, SK, Canada.
A Priori Medical Sciences Inc, Vancouver, BC, Canada.
J Clin Densitom. 2020 Oct-Dec;23(4):549-560. doi: 10.1016/j.jocd.2019.10.001. Epub 2019 Oct 9.
Five-year changes in multisite quantitative ultrasound-assessed speed of sound (SOS in m/s) were studied in a cohort of women and men. The impacts of antiresorptive therapies and menopausal status on SOS were also assessed.
Two SOS assessments, clinical assessments, and comprehensive questionnaires were completed 5 years apart on 509 women and 211 men. Age at first assessment was grouped into: <40 yr, 40-49 yr, 50-59 yr, 60-69 yr, 70-79 yr and 80+ yr. Mean rate of change in SOS at the distal radius and tibia were calculated for each age grouping by sex. SOS changes were stratified by antiresorptive use (yes, no) or menopausal status (premenopausal, postmenopausal, or bilateral oophorectomy).
Mean losses in SOS occurred over the 5 years in almost all age groupings. In women, mean losses in SOS for the <40 yr, 40-49 yr, 50-59 yr, 60-69 yr, 70-79 yr, and 80+ yr age groupings were -59, -83, -107, -92, -80 and -66 (p = 0.30; differences among age groupings) at the radius and -18, -16, -54, -1, -9 and 31 at the tibia (p < 0.05), respectively. In men, mean SOS losses were -101, -56, -69, -67, -83 and -127 at the radius (p = 0.61) and -46, -61, 0, -35, -29, and -26 at the tibia (p = 0.23). At the tibia, women prescribed antiresorptives had a mean increase in SOS (8.6 m/s) whereas untreated participants had a mean loss (-23.0; p < 0.001); there was no significant impact at the distal radius. There were no significant differences in change in SOS among menopausal groups (p > 0.26).
Mean SOS generally declined over 5 years in all age groupings of both sexes. The consistent mean losses in SOS over the age spans investigated are coincident with increasing fracture risk. Women on antiresorptive therapy had increased mean SOS over the 5-year assessment period at the tibia, whereas untreated women had mean losses in SOS.
对一组男性和女性进行了研究,观察其五年间多部位定量超声评估的声速(SOS,单位为米/秒)变化情况。同时还评估了抗吸收疗法和绝经状态对SOS的影响。
对509名女性和211名男性每隔5年进行两次SOS评估、临床评估并填写综合问卷。首次评估时的年龄分为:<40岁、40 - 49岁、50 - 59岁、60 - 69岁、70 - 79岁和80岁及以上。按性别和年龄分组计算桡骨远端和胫骨处SOS的平均变化率。SOS变化按抗吸收药物使用情况(是、否)或绝经状态(绝经前、绝经后或双侧卵巢切除术)进行分层。
在几乎所有年龄组中,SOS在5年间均出现平均下降。在女性中,<40岁、40 - 49岁、50 - 59岁、60 - 69岁、70 - 79岁和80岁及以上年龄组在桡骨处的SOS平均下降值分别为-59、-83、-107、-92、-80和-66(p = 0.30;年龄组间差异),在胫骨处分别为-18、-16、-54、-1、-9和31(p < 0.05)。在男性中,桡骨处的SOS平均下降值分别为-101、-56、-69、-67、-83和-127(p = 0.61),胫骨处分别为-46、-61、0、-35、-29和-26(p = 0.23)。在胫骨处,服用抗吸收药物的女性SOS平均增加(8.6米/秒),而未接受治疗的参与者SOS平均下降(-23.0;p < 0.001);在桡骨远端未观察到显著影响。绝经组间SOS变化无显著差异(p > 0.26)。
在所有年龄段的男性和女性中,SOS在5年间总体呈下降趋势。在所研究的年龄跨度内,SOS持续出现平均下降,这与骨折风险增加相一致。在5年评估期内,接受抗吸收治疗的女性在胫骨处的SOS平均增加,而未接受治疗的女性SOS平均下降。